TET2 and acute myeloid leukemia: In this study, we performed a comprehensive analysis of 206 patients with cytogenetically normal acute myeloid leukemia to investigate the clonal characteristics of TET2 mutations and their prognostic impact, with a particular focus on the clinical outcomes associated with dominant versus subclonal TET2 mutations.